Acute myelogenous leukemia: advances and limitations of treatment. [electronic resource]
- Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics Mar 2002
- 257-63 p. digital
Publication Type: Case Reports; Comparative Study; Journal Article; Review
1079-2104
10.1067/moe.2002.121988 doi
Adult Aminoglycosides Anthracyclines--therapeutic use Anti-Bacterial Agents--therapeutic use Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Antigens, CD--metabolism Antigens, Differentiation, Myelomonocytic--metabolism Antimetabolites, Antineoplastic--therapeutic use Antineoplastic Agents--therapeutic use Benzamides Case-Control Studies Cytarabine--therapeutic use Fatal Outcome Gemtuzumab Gingiva--pathology Hematopoietic Stem Cell Transplantation Humans Imatinib Mesylate Immunosuppressive Agents--therapeutic use Immunotoxins--therapeutic use Leukemia, Myeloid, Acute--therapy Leukemic Infiltration Male Piperazines--therapeutic use Pyrimidines--therapeutic use Remission Induction Sialic Acid Binding Ig-like Lectin 3